Federal Circuit: Aggregated Financial Data From Different Products That Practice Different Patents Insufficient to Establish Domestic Industry

July 10, 2024

Reading Time : 2 min

In an appeal from the ITC, the Federal Circuit recently held that by presenting cumulative financial data across different products that practice various combinations of patents, appellant provided insufficient evidence for a court to evaluate domestic industry for any individual patent. And as a result, the court affirmed the ITC’s determination that the appellant failed to satisfy its burden to establish a domestic industry for any of its asserted patents.

The technology in this case related to stud finders. The appellant in this case asserted three patents each of which covered different features of its stud finder technology, including methods of calibration and features of the grips. In an effort to show domestic industry at the ITC, the appellant alleged that it met the domestic industry requirement based on investments in manufacturing, labor and capital, research and development, and the exploitation of its patents. As evidence of these investments, appellant provided financial data across 53 different products. Not all 53 products, however, practiced all three patents. Rather, only 14 of the 53 products practiced at least one claim of each asserted patent. The remaining products practiced only one or two of the asserted patents. But appellant’s domestic industry evidence aggregated the financial data for all products—it did not allocate the investments separately by product or patent.

At the ITC, the administrative law judge (ALJ) found that this evidence did not satisfy the economic prong for any of the asserted patents because it did not show a substantial or significant investment specific to any particular patent. On review, the ITC upheld the ALJ’s determination, explaining that instead of establishing domestic industry for products protected by each asserted patent, the complainant “aggregated its domestic industry products without regard for whether or which patents they practiced and then argued that a domestic industry in all of its products exists.” The aggregated information “failed to provide the Commission with an adequate basis to evaluate the investments and the significance of those investments with respect to each asserted patent.”

On appeal, appellant argued that Section 337 permits it to rely on investment data in the aggregate, so long as it ties expenditures to articles that practice some or all of the asserted patents. In other words, it need not show investments on a patent-by-patent basis.

The Federal Circuit rejected this argument, adopting the reasoning of the ALJ and ITC. As the court explained, a complainant must show “how much of its investment in each statutory category was attributable to each group of products” that practices an asserted patent. Thus, while it may be possible to aggregate data in certain circumstances, such as where all of the products practice all of the patents, such a method was inappropriate here where many of the products practiced fewer than all of the asserted patents. The court also confirmed its decision here does not preclude a party from grouping data for products that practice the same patents, so long as domestic industry can be determined for each patent.

Practice Tip: This case illustrates that, similar to damages apportionment, parties should give attention to ensuring that domestic industry evidence connects specific products to the specific patents they practice and does not depend on data for products that are not covered by the claims.

Zircon Corp. v. Int’l Trade Comm’n, 101 F.4d 817, 818 (Fed. Cir. 2024).

Share This Insight

Previous Entries

IP Newsflash

March 24, 2025

The Federal Circuit affirmed a Patent Trial and Appeal Board (PTAB) final written decision holding that the prior art exception of AIA Section 102(b)(2)(B) does not apply to a prior sale by an inventor when the sale is conducted in private. According to the Federal Circuit, a sale must disclose the relevant aspects of the invention to the public to qualify for the prior art exception of Section 102(b)(2)(B).

...

Read More

IP Newsflash

March 21, 2025

Under the Lanham Act, a plaintiff who prevails on a trademark infringement claim may be entitled to recover the “defendant’s profits” as damages. The Supreme Court in Dewberry Group, Inc. v. Dewberry Engineers Inc. unanimously construed “defendant’s profits” in 35 USC § 1117(a) to mean that only the named defendant’s profits can be awarded, not the profits of other related corporate entities. The Court, however, left open the possibility that other language in § 1117(a) may allow for damages linked to the profits of related entities, if properly raised and supported.

...

Read More

IP Newsflash

March 13, 2025

In a series of rulings on a motion in limine, the District of Delaware recently distinguished between what qualifies as being incorporated by reference and what does not for the purposes of an anticipation defense. In short, a parenthetical citation was held to be insufficient, while three passages discussing a cited reference met the test.

...

Read More

IP Newsflash

March 4, 2025

On February 28, 2025, the USPTO announced that it was rescinding former Director Vidal’s 2022 memorandum on discretionary denials by the Patent Trial and Appeal Board. The 2022 memorandum effectively narrowed the application of discretionary denials in cases with parallel district court litigation by specifying instances where discretionary denial could not be issued. With the withdrawal of the memorandum, individual PTAB panels will regain flexibility in weighing discretionary denials. While the long-term effect of that increased flexibility is not yet known, the immediate effect is likely to be a shift towards the discretionary analysis applied by PTAB panels before the issuance of the memorandum.

...

Read More

IP Newsflash

March 3, 2025

A District of Delaware judge recently granted a defendant’s motion to include a patent prosecution bar in its proposed protective order after determining that litigation counsel’s ability to practice before the Patent Office—without ever having represented the plaintiffs at the Patent Office in the past—weighed heavily in favor of the bar.

...

Read More

IP Newsflash

February 12, 2025

The Federal Circuit recently reversed a district court decision that found a patent that did not describe after-arising technology failed to satisfy the written description requirement. In so doing, the Federal Circuit explained that written description and enablement are evaluated based on the subject matter that is claimed, not the products that practice those claims. As a result, the patentee was not required to describe unclaimed, later-discovered features of the accused products despite the broad language in the claims that undisputedly covered the products.

...

Read More

IP Newsflash

January 24, 2025

The District of Delaware recently rejected a patentee’s argument that non-production of an opinion letter from counsel, combined with knowledge of the patent, warranted a finding that defendant induced infringement.

...

Read More

IP Newsflash

January 17, 2025

The District of Delaware recently denied a motion to dismiss a patent infringement complaint involving gene editing technology that sought relief under the Safe Harbor Provision of the Hatch-Waxman Act. Specifically, the court found the patentee’s complaint sufficiently alleged at least some uses of the claimed technology that, when taken as true, were not solely uses of a “patented invention” that were “reasonably related” to an FDA submission.

...

Read More

© 2025 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.